Am J Physiol Cell Physiol Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 290: C271-C281, 2006. First published September 7, 2005; doi:10.1152/ajpcell.00160.2005
0363-6143/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/C271    most recent
00160.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varela-Nallar, L.
Right arrow Articles by Inestrosa, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varela-Nallar, L.
Right arrow Articles by Inestrosa, N. C.

NERVOUS SYSTEM CELL BIOLOGY

Induction of cellular prion protein gene expression by copper in neurons

Lorena Varela-Nallar,1,2 Enrique M. Toledo,1 Luis F. Larrondo,2 Ana L. B. Cabral,3,4 Vilma R. Martins,3 and Nibaldo C. Inestrosa1,2

1Centro de Regulación Celular y Patología "Joaquín V. Luco", and 2Millenium Institute for Fundamental and Applied Biology, Facultad de Ciencias Biológicas, P. Universidad Católica de Chile, Santiago, Chile; 3Ludwig Institute for Cancer Research, São Paulo; and 4Departamento de Bioquímica, Instituto de Química da Universidade de São Paulo, São Paulo, Brazil

Submitted 6 April 2005 ; accepted in final form 31 August 2005


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Prion diseases are caused by the conformational transition of the native {alpha}-helical cellular prion protein (PrPC) into a {beta}-sheet pathogenic isoform. However, the normal physiological function of PrPC remains elusive. We report herein that copper induces PrPC expression in primary hippocampal and cortical neurons. PrPC induced by copper has a normal glycosylation pattern, is proteinase K-sensitive and reaches the cell surface attached by a glycosyl phosphatidylinositol anchor. Immunofluorescence analysis revealed that copper induces PrPC levels in the cell surface and in an intracellular compartment that we identified as the Golgi complex. In addition, copper induced the activity of a reporter vector driven by the rat PrPC gene (Prnp) promoter stably transfected into PC12 cells, whereas no effect was observed in glial C6 clones. Also cadmium, but not zinc or manganese, upregulated Prnp promoter activity in PC12 clones. Progressive deletions of the promoter revealed that the region essential for copper modulation contains a putative metal responsive element. Although electrophoretic mobility shift assay demonstrated nuclear protein binding to this element, supershift analysis showed that this is not a binding site for the metal responsive transcription factor-1 (MTF-1). The MTF-1-independent transcriptional activation of Prnp is supported by the lack of Prnp promoter activation by zinc. These findings demonstrate that Prnp expression is upregulated by copper in neuronal cells by an MTF-1-independent mechanism, and suggest a metal-specific modulation of Prnp in neurons.

neuronal cells; Prnp; phosphatidylinositol-specific phospholipase; metal responsive element; metal responsive transcription factor-1

PRION DISEASES are a group of fatal transmissible neurodegenerative disorders, which includes kuru and Creutzfeldt-Jakob disease in humans, scrapie in sheep and bovine, spongiform encephalopathy in cattle (48). These pathologies are caused by the conformational transition of the native and predominantly {alpha}-helical cellular prion protein (PrPC) into a significantly more {beta}-sheet-containing pathogenic isoform (PrPSc) (46), which, unlike PrPC, is insoluble in mild detergents and partially resistant to digestion with proteinase K (PK) (13). PrPC expression is required for prion disease because genetically modified mice that lack expression of PrPC are resistant to infection with a mouse prion inoculum (9).

PrPC is a cell surface glycoprotein anchored to the cell membrane by a glycosyl phosphatidylinositol anchor (55). It is mainly expressed in neurons (31) and glial cells (40). The cellular functions of PrPC are still unknown, but it has been related to copper metabolism and oxidative stress, as suggested by its copper binding properties in the NH2 terminal octapeptide repeat region. This copper-binding domain is located between residues 60 and 91 and consists of four identical repeats of the peptide sequence Pro-His-Gly-Gly-Gly-Trp-Gly-Gln (23, 56, 64), which is among the best-conserved regions of PrPC in mammals (65). Copper binding to the octarepeat region reversibly stimulates endocytosis of PrPC from the cell surface, suggesting PrPC acts as a receptor for cellular uptake or efflux of copper (8, 33, 47). Moreover, it has been described that cerebellar cells from PrPC-knockout mice contain only 20% of copper amount present in cells from wild-type animals (7), suggesting that PrPC may be an important copper binding protein in the brain. In addition, we determined that the octarepeat region of the human PrPC (PrP59–91) reduces Cu2+ to Cu1+ in vitro, which depends on the tryptophan residues present in the octapeptide repeats (44, 51). PrP59–91 has a protective effect mediated by the tryptophan residues against copper neurotoxicity in vivo, preventing behavioral impairments and reducing neuronal cell loss and astrogliosis induced by intrahippocampal copper injection (14).

The aforementioned evidence suggests a role for PrPC in the metabolism of copper. Considering that gene expression of proteins related to copper metabolism is stimulated by heavy metals (17, 42, 67), we hypothesized that PrPC levels may be induced by copper. Sequence analysis of the rat PrPC gene (Prnp) promoter revealed an inverted metal responsive element (MRE) and two MRE-like sequences (MLS) that mismatch the consensus core motif in one nucleotide (63). Herein, we studied Prnp modulation by copper, and found that copper induces Prnp expression in both rat hippocampal and cortical neurons. In PC12 cells but not in C6 cells, rat Prnp promoter activity was highly increased by copper. Also, cadmium but not zinc or manganese increased promoter activity in PC12 cells. Although this induction is mediated by a region of the rat Prnp promoter that holds one MLS, electrophoretic mobility shift assays demonstrated that this element does not bind the MRE-transcription factor 1 (MTF-1), suggesting that Prnp promoter activity in neuronal cells is MTF-1 independent. These data point to a specific metal regulation of Prnp expression in neurons and suggest that alternative mechanisms of metal induction may participate in this regulation. Our results give new insights into the mechanisms that regulate Prnp expression and constitute new evidence to support a role for PrPC in neuronal copper homeostasis.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Primary culture of rat hippocampal and cortical neurons. Rat hippocampal and cortical cultures were prepared as described previously with some modifications (1, 11). Hippocampi and cortices from Sprague-Dawley rats at embryonic day 18 were removed, dissected free of meninges in Ca2+/Mg2+-free Hanks’ balanced salt solution (HBSS), and rinsed twice with HBSS by allowing the tissue to settle to the bottom of the tube. After the second wash, the tissue was resuspended in HBSS containing 0.25% (wt/vol) trypsin and incubated for 15 min at 37°C. After three rinses with HBSS, the tissue was mechanically dissociated in plating medium [Dulbecco’s modified Eagle’s medium (GIBCO, Rockville, MD)], supplemented with 10% horse serum (GIBCO), 100 U/ml penicillin, and 100 µg/ml streptomycin by gentle passage through Pasteur pipettes. Dissociated hippocampal and cortical cells were seeded in poly-L-lysine-coated 6-well culture plates at a density of 7 x 105 and 1 x 106 cells per well, respectively, in plating medium. Cultures were maintained at 37°C in 5% CO2 for 2 h before the plating medium was replaced with neurobasal growth medium (GIBCO) supplemented with B27 (GIBCO), 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin. This method resulted in cultures highly enriched for neurons (~5% glia). After 6 days in culture, cells were used for the experiments. Cells were treated with CuCl2 or a copper-glycine complex that was synthesized with the use of CuCl2 and a 2 M excess of glycine, and the pH was adjusted to 7.4 (7). BCS was purchased from Sigma (St. Louis, MO). Quantification of the total cellular copper content was performed as previously described (57).

Cell lines culture. Rat PC12 pheochromocytoma and C6 glioma clones stably transfected with a luciferase reporter vector driven by the rat Prnp promoter region (–2,831 to +47 bp) (52) have been previously described (10). PC12 cells were routinely grown in RPMI medium (Sigma) supplemented with 10% HS, 5% fetal bovine serum (FBS; GIBCO), 100 U/ml penicillin and 100 µg/ml streptomycin. C6 cells were grown in RPMI medium supplemented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. Both cell lines were maintained at 37°C in 5% CO2 atmosphere. Treatments were done in RPMI medium supplemented with antibiotics.

Reverse transcriptase-polymerase chain reaction. Total RNA from primary hippocampal neurons was prepared using TRIzol (Invitrogen, Rockville, MD) according to manufacture’s instruction. Total RNA (3 µg) was subjected to reverse transcription in a total volume of 20 µl comprising 50 pmol oligo dT, 0.5 mM dNTPs, 10 mM DTT, 2.5 mM MgCl2, 2 µl of reaction buffer, and 50 units of Super Script II reverse transcriptase (Invitrogen) for 50 min at 42°C. For PCR, amplification primers used were the following: PrP; sense, 5'-ATGGCGAACCTTGGCTACTT-3'; antisense, 5'-TCATCCCACGATCAGGAAGA-3'; actin; sense, 5'-AGAGGGAAATCGTGCGTGAC-3'; antisense, 5'-GACTCATCGTACTCCTGCTTG-3'. PCR reaction mixture included 2 µl cDNA, 50 pmol of each primer, 0.2 mM dNTPs, 3 mM MgCl2, 2.5 µl reaction buffer, and 1.25 units of Taq DNA polymerase platinum (Invitrogen) in a final volume of 25 µl. Twenty-five cycles of denaturation at 95°C for 0.5 min, annealing at 62°C for 0.5 min, and extension at 72°C for 1 min were performed. Specific PCR products were run on ethidium bromide-stained agarose gel (1.5%) and visualized under UV light.

Cell lysis and PK digestion. Neurons growing on 6-well culture plates were rinsed twice with ice-cold PBS and lysed with 300 µl of ice-cold lysis buffer (10 mM Tris·HCl, pH 7.8, 100 mM NaCl, 10 mM EDTA, 0.5% Nonidet P-40, and 0.5% sodium deoxycholate) on ice for 30 min. Nuclei and large debris were removed by centrifugation at 1,000 g for 5 min (4°C). The proteins in the postnuclear supernatants were precipitated by the addition of 4 volumes methanol (100%) at –20°C, incubated for at least 30 min, and then collected by centrifugation. For PK digestion, the protease was added to the postnuclear supernatant to a final concentration of 20 µg/ml and proteolysis was performed for 30 min at 37°C. The reaction was stopped by the addition of PMSF at a final concentration of 3 mM and incubating the samples on ice for 5 min. Proteins were precipitated with 4 volumes methanol. Precipitated samples were sonicated in SDS-PAGE sample buffer and one-third of postnuclear supernatant samples and total PK-treated samples were analyzed by immunoblotting.

Phosphatidylinositol-specific phospholipase C treatment. For release of plasma membrane PrPC hippocampal neurons were incubated with phosphatidylinositol-specific phospholipase C (PIPLC; 10 mU/ml) (Molecular Probes, Eugene, OR) in serum-free Opti-MEM medium (GIBCO-BRL). After 24 h the media was recovered and proteins were precipitated with 10% TCA for 30 min and then collected by centrifugation. Neurons were rinsed twice with ice-cold PBS and lysed with 300 µl of ice-cold lysis buffer as described above. The proteins in the postnuclear supernatants were precipitated with 10% TCA. Precipitated samples were sonicated in SDS-PAGE sample buffer and 1/4 of postnuclear supernatant sample and the total protein released to the media were analyzed by immublotting.

Immunoblot analysis. Proteins were resolved in SDS-PAGE (14% polyacrylamide), transferred to PVDF membrane and reacted with 8H4 monoclonal antibody (kindly provided by Dr. Man-Sun Sy, Case Western Reserve University School of Medicine), anti-recombinant His6-PrPC antiserum produced in Prnp0/0 mouse (M-203), goat polyclonal anti-PrPC (M20, Santa Cruz Biotechnology, Santa Cruz, CA), goat polyclonal anti-HSP70 (Santa Cruz Biotechnology), monoclonal anti-{beta}-actin (Abcam, Cambridge, MA), rabbit polyclonal anti-{beta}-tubulin (Santa Cruz Biotechnology). The reactions were followed by incubation with anti-mouse, anti-rabbit or anti-goat IgG peroxidase labeled (Pierce, Rockford, IL) and developed using the ECL technique (Amersham Biociences, Piscataway, NJ).

Immunofluorescence. Hippocampal neurons were seeded onto poly-L-lysine-coated coverslips in 24-well culture plates at a density of 5 x 104 cells per well. After 6 days in the culture, the cells were used for the experiments. After treatment, the cells were rinsed twice in ice-cold medium and fixed with a freshly prepared solution of 0.4% paraformaldehyde in PBS for 20 min and permeabilized for 10 min with 0.2% Triton X-100 in PBS. After several rinses in ice-cold PBS, the cells were then incubated in 0.2% gelatin in PBS (blocking solution) for 30 min at room temperature, followed by an overnight incubation at 4°C with the monoclonal antibody 8H4 diluted 1:100. The cells were extensively washed with PBS and then incubated with Alexa 555-conjugated anti-mouse IgG (1:2,000) for 1 h at room temperature. The cells were mounted in mounting medium and analyzed in a Zeiss confocal laser microscope.

Plasmid construction and transient transfection. Five fragments of the rat Prnp promoter gene (GenBank accession no. D50092) (52) were amplified using the following sense primers: 5'-TTAAGTaagcttTTAAAGCCACTTCCTG-3' (p2831); 5'-TTAAGTaagcttTTAAAGCCACTTCCTG-3' (p2636); 5'-CAGCAaagcttATTCTAACAGGCTGAAATCTGGG-3' (p2483); 5'-TTTAaagcttGGTTTATGACCCCTTCTGT-3' (p2150); 5'-TATAaagcttGGGCACATGTCATCCTATGT-3' (p2052); and the single antisense primer: 5'-TgCCaagcttCTgCCACCgACgCgACgCTCAg-3' (lowercase sequences represent the HindIII restriction site in the oligonucleotides). PCR products were cloned into the HindIII site of the Promega pGL3-Basic luciferase reporter vector (Promega, Madison, WI). Plasmid transfection was carried out in 24 wells culture plates with LipofectAMINE 2000 (Invitrogen) according to the manufacturer’s instructions for PC12 cells. Cells were seeded ~2.5 x 105 cells per well in 1 ml of RPMI supplemented with 10% horse serum and 5% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin, and placed in a CO2 incubator at 37°C. After 24 h, the cells were cotransfected with 50 fmol of the plasmid DNA and 100 ng of pSV-{beta}-gal (Promega). After 6 h, the medium was replaced to supplemented RMPI medium. Twenty-four hours posttransfection, the cells were subjected to different treatments.

Luciferase assay. Stably and transiently transfected cells exposed to treatments were rinsed three times in PBS and harvested in 100 µl of 1x luciferase cell culture lysis reagent (Promega). The luciferase activity in cell lysates was measured as relative light units by using the Promega Luciferase Assay System according to the manufacturer’s protocol, with a MD3000 Luminometer (Analytical Luminescence Laboratory). Relative luciferase units of stable clones were normalized for protein concentration, and normalized luciferase activity of each stable clone after treatment was expressed as the fold increase over the equivalent clone without treatment. For transient transfection, relative luciferase units were normalized for {beta}-gal activity, and normalized luciferase activity of cells subjected to treatments were expressed as the fold increase over the untreated cells transfected with the same plasmid.

Electrophoretic mobility shift assay. The MLS1 probe used was the following: sense, 5'-CACTCCTCTCCTGCGTCCCCTGCCATCTCTG-3'; antisense, 5'-TGTCAGAGATGGCAGGGGACGCAGGAGAGGAGTGGGTA-3'. The probe was end labeled using T4 polynucleotide kinase and [{gamma}-32P]ATP. PC12 nuclear extracts were prepared as previously described (2). EMSAs were performed with the Promega GelShift assay system (Promega) according to the manufacturer’s protocol, using 3.5 µg of nuclear extract and 0.5–2 x 105 cpm of the radiolabeled DNA probe per sample. For supershift experiments, 1 µl of anti-MTF-1 antibody (generously provided by Dr. Glen Andrews, Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS) was added to the mixture previously to the addition of the labeled probe.

Statistical analysis. Each experiment was performed in triplicate and mean values represent at least three independent experiments. Statistical significance was tested by Student’s t-test. P < 0.05 was considered statistically significant.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Copper induces the expression of PrPC in cultured rat neurons. Considering that PrPC is normally expressed in neuronal tissues, the effect of copper on the expression of Prnp was assessed in cultured neurons. Total RNA isolated from primary cultured hippocampal neurons with or without treatment with 50 µM CuCl2 for 12 h was analyzed by RT-PCR to evaluate the expression level of Prnp. Densitometric analysis normalized to {beta}-actin mRNA revealed an increase in Prnp mRNA level after copper treatment (Fig. 1A). To evaluate copper modulation at the protein level, hippocampal and cortical neurons were treated with different concentrations of CuCl2 for 24 h and then harvested for immunoblotting analysis of PrPC using the monoclonal antibody 8H4 (68) and {beta}-tubulin as a loading control. Three distinct bands were observed in hippocampal and cortical neurons (Fig. 1, B and C, see arrowheads). The graphs show densitometric analysis of PrPC after normalization to {beta}-tubulin. As observed, PrPC level was significantly induced by 50 µM CuCl2 in both hippocampal and cortical neurons. Similar induction was observed when membranes were probed with anti-rPrPC antiserum produced in Prnp0/0 mouse, or with a goat polyclonal anti-PrPC antibody (not shown).



View larger version (43K):
[in this window]
[in a new window]
  		Fig. 1. Copper induces the expression of cellular prion protein (PrPC) in primary cultured neurons. A: RT-PCR analysis of the expression of PrPC in primary hippocampal neurons untreated or treated with 50 µM CuCl2 for 12 h. Densitometric analysis of visualized bands was carried out with NIH Image J software (version 1.33), and PrP was normalized against {beta}-actin mRNA levels and expressed as the fold increase compared with control cells. Western blot analysis of total cell extracts from hippocampal (B) or cortical (C) neurons untreated or treated with 25, 50, and 100 µM CuCl2 for 24 h, with anti-PrP monoclonal antibody 8H4 or anti-{beta}-tubulin polyclonal antibody. Arrowheads indicate the 3 distinct bands observed. Molecular size markers are indicated as bars on the left side of the panels and represent 36, 24, and 19 kDa. PrP was normalized to {beta}-tubulin levels and expressed as relative (fold) increase over untreated neurons. Bars are means ± SE of 3 independent experiments. *P < 0.05 vs. the single mean Student’s t-test.

 
To mimic the in vivo situation where the exchange of a metal ion is from one protein or ligand to another, copper was also supplied as a copper-glycine complex (7). Because glycine competes for free copper, nonspecific binding to low-affinity sites is avoided. Like CuCl2, treatment with 50 µM copper-glycine complex for 24 h induces PrPC levels in hippocampal neurons (Fig. 2B). The induction of PrPC levels by CuCl2 and copper-glycine complex was inhibited by cotreatment with the Cu1+-specific chelator bathocuproinedisulfonic acid (BCS) (Fig. 2, A and B). This result indicates that elevation of intracellular copper concentration causes the increased expression of PrPC. We determined that treatment with 50 µM CuCl2 for 24 h increased total cellular copper content 5.36 ± 0.32-fold in hippocampal neurons.



View larger version (30K):
[in this window]
[in a new window]
  		Fig. 2. CuCl2 and copper-glycine induction of PrPC expression is inhibited by bathocuproine disulfonic acid (BCS). Primary hippocampal neurons were exposed to 50 µM CuCl2 (A) or copper-glycine complex (Cu-Gly) (B) for 24 h in the presence or absence of 200 µM BCS, and then harvested for immunoblot analysis of PrP and {beta}-actin as loading control. Membranes were stripped and reprobed with anti-heat shock protein 70 (HSP70) antibody.

 
The toxicity of copper treatment was assessed by MTT assay. Cell viability of hippocampal neurons was 91.7 ± 10.6% of the control cells after incubation with 50 µM CuCl2 for 24 h and 95.3 ± 4.4% after treatment with 50 µM copper-glycine complex. The LC50, the concentration that killed half of the cells, was calculated to be 161.9 µM CuCl2 after 24 h of treatment. To determine whether copper treatment induced a stress response that could mediate the effect on the expression of PrPC, we also analyze the effect of copper on the expression of the 70-kDa heat shock protein (HSP70). HSP70 is stress protein induced in response to different stimuli, including heat shock and oxidative stress (26, 37, 39), and therefore has been proposed as a general marker of cellular damage. Treatment with 50 µM CuCl2 or copper-glycine complex for 24 h did not induce HSP70 levels (Fig. 2, A and B), suggesting that these treatments did not induce a general stress response. This is in agreement with a previous report showing that copper concentration required for the induction of HSP70 expression is >200 µM (42).

To assess whether the three bands observed correspond to the bi-, mono-, and unglycosylated forms of PrPC, hippocampal neurons were treated with 5 µg/ml tunicamycin in the presence or absence of 50 µM CuCl2 for 24 h. In both, control and copper treated neurons, there was an enrichment of the lower molecular weight band compared with the other bands, indicating it corresponds to the unglycosylated form of PrPC (Fig. 3A). As expected, an increase in the unglycosylated form of PrPC was observed by copper treatment in the presence of tunicamycin. Apparently no changes in the PrPC glycosylation pattern were induced by copper (Fig. 1B and 3A, in the absence of tunicamycin).



View larger version (40K):
[in this window]
[in a new window]
  		Fig. 3. Copper-induced PrP has a normal glycosylation pattern is proteinase K sensitive and reaches the cell surface. A: primary hippocampal neurons were exposed to 50 µM CuCl2 in the presence or absence of 5 µg/ml tunicamycin for 24 h and then harvested for immunoblotting analysis of PrP. Arrowheads indicate the three distinct bands observed. Blot was probed with anti-{beta}-tubulin antibody as loading control. B: cell lysates of hippocampal neurons untreated or treated with 25, 50, 100 µM CuCl2 for 24 h were digested with 20 µg/ml PK 30 min at 37°C, and then analyzed by immunoblotting. C and D: neurons were incubated for 24 h with 50 µM CuCl2 in the presence or absence of 10 mU/ml phosphatidylinositol-specific phospholipase (PIPLC). The collected medium (D) and cell lyasates (C) were analyzed by immunoblotting. In all experiments PrP was detected with the anti-PrP monoclonal antibody 8H4. Molecular size markers are indicated as bars on the left side of the panel and represent 34 and 26 kDa.

 
In vitro, copper converts PrPC into a detergent-insoluble and PK-resistant specie (49, 66) suggesting that copper may have a role in the conversion of PrPC into PrPSc. To determine whether copper induces PK resistance of PrPC in neurons, detergent extracts of hippocampal neurons incubated with different concentrations of CuCl2 for 24 h were digested with PK and then assayed by immunoblotting with anti-PrP 8H4. As shown in Fig. 3B, no PK-resistant PrP was detected in control or copper-treated neurons.

It has been observed in N2a cells and hippocampal neurons that copper induces detergent insoluble PrP, suggesting it induces PrPC misfolding and aggregation (28, 62). This aggregation may be associated to the biosynthetic pathway and occurs during normal protein folding or intracellular trafficking. To study whether PrPC reaches the cell surface in the presence of copper, neurons were treated with PIPLC during copper exposure. As shown in Fig. 3C, there was a decrease of PrPC in the cell extracts from hippocampal neurons treated with 10 mU/ml PIPLC in the presence or absence of 50 µM CuCl2 for 24 h, indicating that most of PrPC got to the cell surface during the treatment. In agreement, there was an increase of PrPC in the media of PIPLC-treated neurons (Fig. 3D). PrPC detected in the media migrates as the mature biglycosylated form of PrPC. The increase of PrPC in the medium of PIPLC-treated neurons was higher in the presence of copper, supporting that the metal induces the expression of cell surface PrPC.

The effect of copper on PrPC level was also evaluated by immunofluorescence in permeabilized hippocampal neurons. PrPC was localized in the cell bodies and neurites of control and copper treated neurons (Fig. 4, A and B, respectively). A considerable increase in the fluorescence intensity was observed in neurons treated with 50 µM CuCl2 for 24 h (Fig. 4B) compared with control neurons (Fig. 4A). This induction was observed in the cell surface staining and also in an intracellular compartment that we identified as the Golgi complex, as it colocalize with the Golgi marker giantin (36) (not shown).



View larger version (73K):
[in this window]
[in a new window]
  		Fig. 4. Cell localization of copper-induced PrPC in hippocampal neurons. Immunodetection of PrPC in cultured rat hippocampal neurons untreated (A) or treated with 50 µM CuCl2 for 24 h (B) was carried out using the anti-PrP monoclonal antibody 8H4 and a secondary antibody conjugated with Alexa 555. Original magnification x60. Scale bars indicate 10 µm.

 
Copper induces Prnp promoter activity in PC12 cells but not in C6 cells. To assess the stimulatory effect of copper on the rat Prnp promoter activity, PC12 and C6 clones stably transfected with a luciferase reporter vector driven by the rat Prnp promoter were used (10). Three different clones of each cell line were treated with 100 µM CuCl2 for 16 h. As shown in Fig. 5A, a large increase of 20- to 40-fold in promoter activity was observed in all PC12 clones analyzed. On the other hand, copper did not induce Prnp promoter activity in any of the C6 clones studied (Fig. 5A). Cell viability under this condition was 85.49 ± 6.96% for PC12 cells and 105.32 ± 3.78% for C6 cells, as assessed by MTT assay.



View larger version (20K):
[in this window]
[in a new window]
  		Fig. 5. Copper induces rat PrPC gene (Prnp) promoter activity in PC12 but not in C6 glial clones. A: PC12 and C6 clones stably transfected with a luciferase reporter vector driven by the rat Prnp promoter were treated with 100 µM CuCl2 for 16 h. Luciferase activity of each clone after treatment was expressed as the relative increase over the equivalent untreated clone. PC12 clones were treated with 100 µM CuCl2 for 8, 16, and 24 h (B) or with 10, 50, 100, and 200 µM CuCl2 for 24 h (C). Bars are means ± SE of 3 independent experiments, each carried out in duplicate. *P < 0.05 vs. single mean Student’s t-test.

 
PC12 clones were treated with 100 µM CuCl2 for different incubation periods (Fig. 5B), or with different concentrations of CuCl2 for 24 h (Fig. 5C). Because metal-inducible genes have unique dose-response curves, we used a concentration range that induces gene transcription of different mammalian genes (42, 67). A time- and concentration-dependent increase in luciferase activity was observed in the three clones studied. No promoter induction was observed in any of the C6 clones even in the presence of 200 µM CuCl2 (data not shown). Taken together, these data demonstrate that copper activates Prnp transcription in neuronal cells suggesting that Prnp expression is regulated by copper concentration in neurons.

The effect of other heavy metals, which are known to induce transcription of metal-related proteins like metallothioneins and Cu/Zn superoxide dismutase (SOD-1), was evaluated. Treatment of PC12 clones with different concentrations of CdCl2 for 24 h increased luciferase activity in all clones studied (Fig. 6A). In contrast, no effect was observed with ZnCl2 (Fig. 6B) treatment. In addition, we analyzed the effect of manganese, which has been demonstrated to bind to recombinant PrPC. The binding of manganese induces changes in the normal structure of PrP causing the protein to form aggregates (34, 60), and converts PrP into an abnormal form rich in {beta}-sheet structure and is PK resistant (6, 34). No effect on Prnp promoter activity was observed in PC12 clones treated with 10, 50, and 100 µM of MnCl2 for 24 h (Fig. 6C), suggesting that manganese is unable to modulate Prnp transcription. These results indicate that there is a metal-specific regulation of Prnp expression.



View larger version (12K):
[in this window]
[in a new window]
  		Fig. 6. Metal-specific induction of Prnp promoter activity. PC12 clones stably transfected with the luciferase reporter vector driven by the rat Prnp promoter were treated with different concentrations of CdCl2 (A), ZnCl2 (B), or MnCl2 (C). Luciferase activity of each clone after treatment was expressed as the fold increase over the equivalent untreated clone. Bars are means ± SE.

 
Copper induction of Prnp expression is mediated by the promoter region –2,831 to –2,150 bp and is independent of MTF-1. Metallothionein (MT) genes are among the best studied heavy metal inducible genes, in which transcription is mediated through MREs present in multiple copies in the MT promoter region (12, 16, 27). The MRE constitutes an imperfectly conserved 12 base pair sequence motif, consisting of a highly conserved 7-base pair functional core motif [5'-TGC(A/G)CNC] flanked by a less conserved 5-base pair GC-rich domain (19). Sequence analysis of the upstream region of the rat Prnp revealed an inverted MRE located at position –2,070 (GGGCTGTGTGCA) and two MRE-like sequences (MLS) that mismatch the consensus core motif in one nucleotide (–2,653 TGCGtCCCCTGC; –2,599 TGCGgTCACCCT) (63) (Fig. 7A). To determine whether these elements are implicated in the copper-mediated induction of Prnp, a series of luciferase constructs containing progressive deletions of the Prnp promoter were transiently transfected into PC12 cells (Fig. 7A). The reporter vector containing the entire Prnp promoter (p2831), previously used to generate PC12 and C6 clones, was induced after treatment with 100 µM CuCl2 for 16 h (Fig. 7B). Deletion of the region that contains the MLS1 (p2636), significantly decreased the effect of copper on promoter activity raising the possibility that MLS1 is important for copper upregulation of Prnp. No additional effect was observed when MLS2 was deleted (p2483). Deletion of the region between –2,483 and –2,150, which does not contain MLSs or MRE sequences, also seems to participate in copper-mediated induction of Prnp expression.



View larger version (17K):
[in this window]
[in a new window]
  		Fig. 7. Copper induction of the rat Prnp expression is mediated by the promoter region –2,831 to –2,150 bp. A: schematic representation of the luciferase reporter gene constructs with progressive deletions of the rat Prnp promoter. In the construction p2831, the metal responsive element (MRE) and MRE-like sequences (MLSs) found in the promoter region are indicated in black bars. The highly conserved 7-base pair functional core motifs are indicated in bold letters and the flanking less conserved 5-base pair GC-rich domains are indicated in italic letters. Lower case letters indicate mismatches from the consensus MRE sequence. B: PC12 cells transiently transfected with each construct were treated with 100 µM CuCl2 for 16 h and luciferase activity was measured and normalized for {beta}-galactosidase activity. Normalized luciferase activities of treated cells were expressed as the fold increase compared with the untreated PC12 cells transfected with the same plasmid. Bars are means ± SE of 4 independent experiments. *P < 0.05 according to the Student’s t-test.

 
MRE sequences are recognized by the transcription factor MTF-1, which is responsible for the induction of gene transcription by heavy metals, such as zinc, cadmium, and copper (22, 45). To elucidate whether MTF-1 binds to the MLS1 in the rat Prnp promoter, an oligonucleotide corresponding to this element was used to examine the binding of PC12 nuclear proteins using EMSA. MLS1 associates with nuclear proteins from PC12 cells in the presence or absence of 100 µM CuCl2 for 16 h (Fig. 8A, lanes 2 and 5, respectively). These complexes disappeared when unlabeled oligonucleotide was added to the reaction mixture in 200-fold excess (Fig. 8A, lanes 3 and 6). The formation of protein-DNA complexes was not inhibited by the addition of 1,000-fold excess of a nonspecific competitor corresponding to the element for the basal transcription factor Sp1 (Fig. 8A, lanes 4 and 7). Despite the fact that MTF-1 is expressed in PC12 cells as evaluated by immunoblotting (data not shown), MLS1-nuclear protein complexes were not supershifted by an anti-MTF-1 antibody (Fig. 7B, lanes 3 and 5) that has been previously shown to supershift MTF-1 (18, 32). These data indicate that MTF-1 is not part of the formed complexes and strongly suggests that copper induction of Prnp expression is MTF-1 independent.



View larger version (39K):
[in this window]
[in a new window]
  		Fig. 8. MTF-1 does not bind to the rat Prnp promoter. A: protein-DNA interactions assays were conducted using 32P-labeled MLS1 oligonucleotide, which was incubated with nuclear extract (NE) from untreated PC12 cells (lanes 2–4) or copper treated cells (lanes 5–7). Lane 1, labeled probe without nuclear extract; lanes 2 and 5, probe plus nuclear extract; lanes 3 and 6, competition analysis performed in the presence of 200-fold molar excess of unlabeled probe, lanes 4 and 7, competition with 1,000-fold excess of unlabeled Sp1 oligonucleotide. B: supershift analysis with anti-MTF-1 antiserum of the MLS1 probe plus nuclear extract from untreated (lanes 2 and 3) or copper treated (lanes 4 and 5) cells. Brackets indicate DNA protein complexes.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The PrPC is a normal cellular protein that has been related to prion diseases (48). Besides other physiological functions of PrPC, its involvement in copper uptake and metabolism has been largely discussed (7, 33, 47, 51). In the present work, we studied the effect of copper on the expression of PrPC in neurons. Our results indicate that copper upregulates Prnp expression in primary cultured neurons, which is observed at mRNA and protein levels. Prnp promoter activity in response to copper was also evaluated; a time- and concentration-dependent increase of promoter activity was observed in PC12 clones but not in C6 clones stably transfected with a luciferase reporter vector driven by the rat Prnp promoter, suggesting that Prnp expression is specifically regulated by copper concentration in neurons. The absence of stimulation of Prnp promoter activity in C6 clones is not a consequence of a nonfunctional insertion of the plasmid because it was previously demonstrated that treatment with Trichostatin A, an histone deacetylase inhibitor, increased Prnp promoter activity in all clones used in the present study (10).

Induction of PrPC expression was observed when copper was provided as CuCl2 or as a copper-glycine complex, and was prevented by cotreatment with BCS. BCS is an impermeable Cu1+-specific chelator that inhibits copper transport into the cell. This indicates that increased intracellular copper concentration might be responsible for the induction of PrPC expression by CuCl2 and copper glycine treatments. In agreement, we determined that the cellular copper content was increased by CuCl2 treatment. However, this treatment induced very low neuronal toxicity and did not induce the expression of the stress marker HSP70. The heat shock or stress response is characterized by an increase in transcription and translation of HSP70 (29). These data suggest that no stress response was induced by treatment with 50 µM Cu2+.

A recent study (59) determined that physiological concentrations of copper (5–40 µM) for 96 h decrease PrPC mRNA levels in the neuronal GN11 cells. We observed that concentrations lower than 50 µM were unable to induce the expression of PrPC, although we did not observe a decrease of PrPC in hippocampal and cortical neurons. However, we did never expose primary cultured neurons to copper treatment for >24 h. Another recent study (3) determined, with the use of cDNA microarrays, that Prnp is upregulated in fibroblast cells from mice with mutations in the ATP7A copper transporting P-type ATPase gene, which accumulate high levels of copper due to a defect in cellular copper export. This suggests that increased copper concentrations associated to dysfunction of copper metabolism may induce the expression of PrPC, supporting our findings in neuronal cells. A possible explanation for the contrasting results on Prnp modulation could be that different cell types have different responses to copper exposure, which could explain the absence of induction of Prnp promoter activity in C6 glial cells. A cell type-specific regulation has been previously observed for MTs gene expression. MT-IIA, MT-IF, and the MT-IG genes are differentially expressed in different cell lines in response to cadmium, copper, and zinc (25). The authors concluded that cell type-specific regulation of MT genes seems to be correlated to DNA methylation of cis-acting elements and the chromatin structure, and that the differential induction of MT gene expression in response to heavy metals may be related to the level of trans-acting factors present in a particular cell line. We have previously determined that Prnp expression is dependent on chromatin conformation (10). Further analysis would be necessary to test whether chromatin structure might modulate copper effects on Prnp expression.

Copper modulation of Prnp expression strongly supports a functional link between PrPC and copper. Another protein that has also been related to copper metabolism is the amyloid precursor protein (APP), which is related to Alzheimer’s disease (21). APP possesses two copper binding domains, located in its NH2 terminal region (61) and in the COOH terminal region within the A{beta} domain (4), and reduces Cu2+ to Cu1+ (41, 50). As observed for PrPC, APP expression is modulated by copper concentration. Human fibroblasts overexpressing a copper efflux protein, the Menkes protein, that have severely depleted intracellular copper, show reduced APP protein levels and downregulated APP gene expression (5). In addition, APP gene is upregulated in fibroblast cells from mice with mutations in the ATP7A gene (3), which have high intracellular copper content. Overall, this evidence further supports a role for both proteins, APP and PrPC, to function in copper homeostasis (24).

In N2a cells copper induces changes in PrPC detergent solubility and intracellular retention (28). In addition, we have observed that hippocampal neurons incubated with copper containing media produce detergent-insoluble PrP aggregates with an abnormal glycosylation pattern in which the monoglycosylated form seems to predominate, suggesting that copper alters PrPC biosynthetic folding and/or trafficking leading to accumulation of immature forms (62). Herein, we observed that in the presence of copper most of PrPC reaches the cell surface attached by a glycosyl phosphatidylinositol anchor because it was released by PIPLC treatment. This suggests that exocytic transport of PrPC to the cell surface is not prevented by copper treatment in neurons. It is known that copper induces endocytosis of PrPC (47), thus it is possible that copper may exert an effect on PrPC after it reaches the cell surface, probably during recycling or degradation. Our efforts are currently concentrated on this hypothesis.

In vitro copper converts PrPC into a detergent-insoluble and PK-resistant specie (49, 66). In addition, copper enhances PK resistance of PrPSc (54) and facilitates restoration of PK resistance and infectivity of guanidine-denatured PrPSc (38). This evidence strongly points to a role of copper in the conversion process of PrPC into PrPSc. Our results showed that copper treatment that induces the expression of Prnp did not induce PK-resistant PrP specie in primary hippocampal neurons. Although we cannot eliminate the possibility that PrP could acquire protease resistance after longer exposure to elevated concentrations of copper.

Manganese is able to convert PrPC into a {beta}-sheet rich and PK resistant molecule (6, 20), and has a proaggregational effect inducing association of PrP oligomers to larger aggregates (34, 60). Moreover, scrapie-infected mice present a metal imbalance, characterized by systemic increase of manganese (30, 58). This evidence suggests that this metal may participate in the conversion of PrPC into PrPSc. We evaluated whether manganese also has an effect on Prnp gene expression, and found that it was unable to regulate Prnp promoter activity in PC12 clones. This indicates that the proposed role of manganese might be exclusively a consequence of the effects of this metal on the structure of PrP and is independent of changes in Prnp expression.

We also analyzed the effect of other heavy metals on Prnp promoter activity and demonstrated that cadmium strongly induced Prnp promoter in PC12 clones, whereas zinc had no effect. This is different to what is observed for metallothioneins and Cu/Zn SOD-1 genes, which are induced by copper, cadmium, and zinc (42, 67). Heavy metal-dependent induction is mediated by multiple MREs located upstream of metallothioneins genes (12, 16, 27), and by a single inverted MRE sequence in the promoter region of the SOD-1 gene (67). In the mouse, it has been also observed that the presence of a single MRE is enough to make some promoters to be target of MTF-1 (35), the transcription factor associated with metal responsiveness (22, 45). Sequence analysis of the rat Prnp promoter revealed the presence of an inverted MRE sequence and two MLSs that match the consensus sequence in six of seven positions (63). This observation raised the possibility that Prnp could be a copper-inducible gene regulated by MRE motifs similarly to metallothioneins and SOD-1 genes. Although deletion experiments suggested that MLS1 motif is important for copper upregulation of Prnp promoter activity, supershift analysis of the EMSA complexes revealed no MTF-1 binding to this motif. These results suggest that copper modulation of Prnp in neuronal cells is independent of MTF-1, which is in agreement with the absence of activation of the Prnp promoter by zinc, a well known inducer of DNA binding activity of MTF-1. As determined by immunoblot analysis, MTF-1 is expressed in PC12 cells as well as in C6 glial cells (not shown), supporting a cell type-specific regulation of Prnp expression by copper independent of MTF-1. Previously, it was shown in the human neuroblastoma cells IMR-32 that zinc does not activate the metallothionein-1 gene promoter (15). Moreover, cadmium-mediated MRE activation in this neuroblastoma cells is independent of MTF-1 (15). Taken together, these observations suggest that specific mechanisms for metal-induced transcription may occur in neuronal cells.

Our data provides new information about the regulatory mechanisms that control PrPC expression. Copper is an essential trace element that is required for the catalytic activity of a number of enzymes. The ability of copper to undergo reversible redox changes makes it a useful cofactor in redox reactions; however, the redox transition can also result in generation of reactive oxygen species by Fenton reaction, which can be toxic to cells. Thus tightly regulated cooper homeostatic mechanisms are needed to control copper concentration and to prevent cellular toxicity. Metals participate directly as signals transducers in the regulation of uptake and detoxification pathways (43). The finding that copper induces Prnp expression is consistent with a role of PrPC in these pathways, and is compatible with a role for PrPC as part of a stress response mechanism. Previously, Prnp expression was shown to be upregulated by heat shock through heat-shock elements present in its promoter (–680 and –1,653 bp) (53), and sequence analysis of the promoter region of Prnp revealed the presence of two antioxidant response elements at –688 and –194 bp. The induction of the Prnp promoter activity by copper and heat shock treatments, and the presence of putative antioxidant response elements strongly suggest that PrPC might be induced in cellular stress responses.

The finding that copper induces Prnp expression in neurons strongly supports a role of PrPC in neuronal copper homeostasis. Future experiments should consider whether this induction has an effect on the appearance and progression of prion diseases.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by grants from International Copper Association (New York, NY), the Center for Research on Metals and Metallurgy-Chile; Fondo de Investigación Avanzada en Áreas Prioritarias-Biomedicine Grant 13980001; Millenium Institute for Fundamental and Applied Biology Grant 2398969, and Fundação de Amparo à Pesquisa do Estado de São Paulo Grant 99/07124-8. L. Varela-Nallar and A. L. B. Cabral are predoctoral fellows from Comisión Nacional de Investigación Cientifica y Tecnológia and Fundação de Amparo à Pesquisa do Estado de São Paulo, respectively.


   ACKNOWLEDGMENTS
 
We thank Dr. Mauricio Gonzalez (Instituto de Nutricion y Tecnologia de Alimentos, Chile) for measurements of copper, and Loreto Cuitino for help in the early phases of this work.


   FOOTNOTES
 

Address for reprint requests and other correspondence: N. Inestrosa, CRCP, Biomedical Center, P. Catholic Univ. of Chile, Alameda 340, Santiago, Chile (e-mail: ninestr{at}bio.puc.cl)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
1. Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, and Inestrosa NC. Wnt-3a overcomes {beta}-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297: 186–196, 2004.[CrossRef][ISI][Medline]

2. Andrews NC and Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.[Free Full Text]

3. Armendariz AD, Gonzalez M, Loguinov AV, and Vulpe CD. Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol Genomics 20: 45–54, 2004.[Abstract/Free Full Text]

4. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, and Bush AI. Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid {beta}1–42. J Neurochem 75: 1219–1233, 2000.[CrossRef][ISI][Medline]

5. Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, and Camakaris J. Copper depletion down-regulates expression of the Alzheimer’s disease amyloid-{beta} precursor protein gene. J Biol Chem 279: 20378–20386, 2004.[Abstract/Free Full Text]

6. Brown DR, Hafiz F, Glasssmith LL, Wong BS, Jones IM, Clive C, and Haswell SJ. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J 19: 1180–1186, 2000.[CrossRef][ISI][Medline]

7. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, Bohlen Av Schulz-Schaeffer W, Giese A, Westaway D, and Kretzschmar H. The cellular prion protein binds copper in vivo. Nature 390: 684–687, 1997.[Medline]

8. Brown LR and Harris DA. Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J Neurochem 87: 353–363, 2003.[CrossRef][ISI][Medline]

9. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1347, 1993.[CrossRef][ISI][Medline]

10. Cabral AL, Lee KS, and Martins VR. Regulation of the cellular prion protein gene expression depends on chromatin conformation. J Biol Chem 277: 5675–5682, 2002.[Abstract/Free Full Text]

11. Caceres A, Banker G, Steward O, Binder L, and Payne M. MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Brain Res 315: 314–318, 1984.[Medline]

12. Carter AD, Felber BK, Walling MJ, Jubier MF, Schmidt CJ, and Hamer DH. Duplicated heavy metal control sequences of the mouse metallothionein-I gene. Proc Natl Acad Sci USA 81: 7392–7396, 1984.[Abstract/Free Full Text]

13. Caughey B and Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266: 18217–18223, 1991.[Abstract/Free Full Text]

14. Chacon MA, Barria MI, Lorca R, Huidobro-Toro JP, and Inestrosa NC. A human prion protein peptide [PrP(59–91)] protects against copper neurotoxicity. Mol Psychiatry 8: 853–862, 835, 2003.[CrossRef][ISI][Medline]

15. Chu WA, Moehlenkamp JD, Bittel D, Andrews GK, and Johnson JA. Cadmium-mediated activation of the metal response element in human neuroblastoma cells lacking functional metal response element-binding transcription factor-1. J Biol Chem 274: 5279–5284, 1999.[Abstract/Free Full Text]

16. Culotta VC and Hamer DH. Fine mapping of a mouse metallothionein gene metal response element. Mol Cell Biol 9: 1376–1380, 1989.[Abstract/Free Full Text]

17. Durnam DM and Palmiter RD. Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J Biol Chem 256: 5712–5716, 1981.[Abstract/Free Full Text]

18. Ghoshal K, Majumder S, Li Z, Dong X, and Jacob ST. Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation. J Biol Chem 275: 539–547, 2000.[Abstract/Free Full Text]

19. Giedroc DP, Chen X, and Apuy JL. Metal response element (MRE)-binding transcription factor-1 (MTF-1): structure, function, and regulation. Antioxid Redox Signal 3: 577–596, 2001.[CrossRef][ISI][Medline]

20. Giese A, Levin J, Bertsch U, and Kretzschmar H. Effect of metal ions on de novo aggregation of full-length prion protein. Biochem Biophys Res Commun 320: 1240–1246, 2004.[CrossRef][ISI][Medline]

21. Hardy J and Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297: 353–356, 2002.[Abstract/Free Full Text]

22. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, and Schaffner W. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J 13: 2870–2875, 1994.[ISI][Medline]

23. Hornshaw MP, McDermott JR, Candy JM, and Lakey JH. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 214: 993–999, 1995.[CrossRef][ISI][Medline]

24. Inestrosa NC, Cerpa W, and Varela-Nallar L. Copper brain homeostasis: role of amyloid precursor protein and prion protein. IUBMB Life 57: 645–650, 2005.[ISI][Medline]

25. Jahroudi N, Foster R, Price-Haughey J, Beitel G, and Gedamu L. Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure. J Biol Chem 265: 6506–6511, 1990.[Abstract/Free Full Text]

26. Jornot L, Mirault ME, and Junod AF. Differential expression of hsp70 stress proteins in human endothelial cells exposed to heat shock and hydrogen peroxide. Am J Respir Cell Mol Biol 5: 265–275, 1991.[ISI][Medline]

27. Karin M, Haslinger A, Holtgreve H, Richards RI, Krauter P, Westphal HM, and Beato M. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 308: 513–519, 1984.[CrossRef][Medline]

28. Kiachopoulos S, Heske J, Tatzelt J, and Winklhofer KF. Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic 5: 426–436, 2004.[CrossRef][ISI][Medline]

29. Kiang JG and Tsokos GC. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 80: 183–201, 1998.[CrossRef][ISI][Medline]

30. Kim NH, Choi JK, Jeong BH, Kim JI, Kwon MS, Carp RI, and Kim YS. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres. FASEB J 19: 783–785, 2005.[Abstract/Free Full Text]

31. Kretzschmar HA, Prusiner SB, Stowring LE, and DeArmond SJ. Scrapie prion proteins are synthesized in neurons. Am J Pathol 122: 1–5, 1986.[Abstract]

32. LaRochelle O, Stewart G, Moffatt P, Tremblay V, and Seguin C. Characterization of the mouse metal-regulatory-element-binding proteins, metal element protein-1 and metal regulatory transcription factor-1. Biochem J 353: 591–601, 2001.[CrossRef][ISI][Medline]

33. Lee KS, Magalhaes AC, Zanata SM, Brentani RR, Martins VR, and Prado MA. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem 79: 79–87, 2001.[CrossRef][ISI][Medline]

34. Levin J, Bertsch U, Kretzschmar H, and Giese A. Single particle analysis of manganese-induced prion protein aggregates. Biochem Biophys Res Commun 329: 1200–1207, 2005.[CrossRef][ISI][Medline]

35. Lichtlen P, Wang Y, Belser T, Georgiev O, Certa U, Sack R, and Schaffner W. Target gene search for the metal-responsive transcription factor MTF-1. Nucleic Acids Res 29: 1514–1523, 2001.[Abstract/Free Full Text]

36. Linstedt AD and Hauri HP. Giantin, a novel conserved Golgi membrane protein containing a cytoplasmic domain of at least 350 kDa. Mol Biol Cell 4: 679–693, 1993.[Abstract]

37. McDuffee AT, Senisterra G, Huntley S, Lepock JR, Sekhar KR, Meredith MJ, Borrelli MJ, Morrow JD, and Freeman ML. Proteins containing non-native disulfide bonds generated by oxidative stress can act as signals for the induction of the heat shock response. J Cell Physiol 171: 143–151, 1997.[CrossRef][ISI][Medline]

38. McKenzie D, Bartz J, Mirwald J, Olander D, Marsh R, and Aiken J. Reversibility of scrapie inactivation is enhanced by copper. J Biol Chem 273: 25545–25547, 1998.[Abstract/Free Full Text]

39. Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 259: 1409–1410, 1993.[Free Full Text]

40. Moser M, Colello RJ, Pott U, and Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 14: 509–517, 1995.[CrossRef][ISI][Medline]

41. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, and Beyreuther K. The amyloid precursor protein of Alzheimer’s disease in the reduction of copper(II) to copper(I). Science 271: 1406–1409, 1996.[Abstract]

42. Murata M, Gong P, Suzuki K, and Koizumi S. Differential metal response and regulation of human heavy metal-inducible genes. J Cell Physiol 180: 105–113, 1999.[CrossRef][ISI][Medline]

43. O’Halloran TV. Transition metals in control of gene expression. Science 261: 715–725, 1993.[Abstract/Free Full Text]

44. Opazo C, Barria MI, Ruiz FH, and Inestrosa NC. Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. Biometals 16: 91–98, 2003.[CrossRef][ISI][Medline]

45. Palmiter RD. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1. Proc Natl Acad Sci USA 91: 1219–1223, 1994.[Abstract/Free Full Text]

46. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, and Prusiner SB. Conversion of {alpha}-helices into {beta}-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962–10966, 1993.[Abstract/Free Full Text]

47. Pauly PC and Harris DA. Copper stimulates endocytosis of the prion protein. J Biol Chem 273: 33107–33110, 1998.[Abstract/Free Full Text]

48. Prusiner SB. Prions. Proc Natl Acad Sci USA 95: 13363–13383, 1998.[Abstract/Free Full Text]

49. Quaglio E, Chiesa R, and Harris DA. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J Biol Chem 276: 11432–11438, 2001.[Abstract/Free Full Text]

50. Ruiz FH, Gonzalez M, Bodini M, Opazo C, and Inestrosa NC. Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein. J Neurochem 73: 1288–1292, 1999.[CrossRef][ISI][Medline]

51. Ruiz FH, Silva E, and Inestrosa NC. The N-terminal tandem repeat region of human prion protein reduces copper: role of tryptophan residues. Biochem Biophys Res Commun 269: 491–495, 2000.[CrossRef][ISI][Medline]

52. Saeki K, Matsumoto Y, and Onodera T. Identification of a promoter region in the rat prion protein gene. Biochem Biophys Res Commun 219: 47–52, 1996.[CrossRef][ISI][Medline]

53. Shyu WC, Harn HJ, Saeki K, Kubosaki A, Matsumoto Y, Onodera T, Chen CJ, Hsu YD, and Chiang YH. Molecular modulation of expression of prion protein by heat shock. Mol Neurobiol 26: 1–12, 2002.[CrossRef][ISI][Medline]

54. Sigurdsson EM, Brown DR, Alim MA, Scholtzova H, Carp R, Meeker HC, Prelli F, Frangione B, and Wisniewski T. Copper chelation delays the onset of prion disease. J Biol Chem 278: 46199–46202, 2003.[Abstract/Free Full Text]

55. Stahl N, Borchelt DR, Hsiao K, and Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51: 229–240, 1987.[CrossRef][ISI][Medline]

56. Stockel J, Safar J, Wallace AC, Cohen FE, and Prusiner SB. Prion protein selectively binds copper (II) ions. Biochemistry 37: 7185–7193, 1998.[CrossRef][Medline]

57. Tapia L, Gonzalez-Aguero M, Cisternas MF, Suazo M, Cambiazo V, Uauy R, and Gonzalez M. Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. Biochem J 378: 617–624, 2004.[CrossRef][ISI][Medline]

58. Thackray AM, Knight R, Haswell SJ, Bujdoso R, and Brown DR. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 362: 253–258, 2002.[CrossRef][ISI][Medline]

59. Toni M, Massimino ML, Griffoni C, Salvato B, Tomasi V, and Spisni E. Extracellular copper ions regulate cellular prion protein (PrPC) expression and metabolism in neuronal cells. FEBS Lett 579: 741–744, 2005.[CrossRef][ISI][Medline]

60. Tsenkova RN, Iordanova IK, Toyoda K, and Brown DR. Prion protein fate governed by metal binding. Biochem Biophys Res Commun 325: 1005–1012, 2004.[CrossRef][ISI][Medline]

61. Valensin D, Mancini FM, Luczkowski M, Janicka A, Wisniewska K, Gaggelli E, Valensin G, Lankiewicz L, and Kozlowski H. Identification of a novel high affinity copper binding site in the APP(145–155) fragment of amyloid precursor protein. Dalton Trans 00: 16–22, 2004.[CrossRef]

62. Varela-Nallar L, Gonzalez A, and Inestrosa NC. Role of copper in prion diseases: deleterious or beneficial? Curr Pharm Des. In Press.

63. Varela-Nallar L, Toledo EM, Chacon MA, and Inestrosa NC. The functional links between prion protein and copper. Biol Res. In Press.

64. Viles JH, Cohen FE, Prusiner SB, Goodin DB, Wright PE, and Dyson HJ. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci USA 96: 2042–2047, 1999.[Abstract/Free Full Text]

65. Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AR, and Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1: 55–59, 1999.[CrossRef][ISI][Medline]

66. Wong E, Thackray AM, and Bujdoso R. Copper induces increased {beta}-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. Biochem J 380: 273–282, 2004.[CrossRef][ISI][Medline]

67. Yoo HY, Chang MS, and Rho HM. Heavy metal-mediated activation of the rat Cu/Zn superoxide dismutase gene via a metal-responsive element. Mol Gen Genet 262: 310–313, 1999.